Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: PPD DEVELOPMENT LP
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2016-07-08 to 2026-06-30
Current total value of award: $428049
Description: FIRST IN HUMAN RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED SINGLE ASCENDING DOSE (SAD) PHASE I STUDY